Arrowstreet Capital’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.82M | Sell |
247,977
-8,429
| -3% | -$266K | 0.01% | 989 |
|
|
2025
Q1 | $8.4M | Buy |
256,406
+81,490
| +47% | +$2.67M | 0.01% | 861 |
|
|
2024
Q4 | $6.32M | Buy |
174,916
+77,393
| +79% | +$2.8M | 0.01% | 944 |
|
|
2024
Q3 | $3.04M | Buy |
+97,523
| New | +$3.04M | ﹤0.01% | 1121 |
|
|
2023
Q1 | – | Sell |
-39,105
| Closed | -$1.4M | – | 1517 |
|
|
2022
Q4 | $1.4M | Buy |
39,105
+30,061
| +332% | +$1.07M | ﹤0.01% | 955 |
|
|
2022
Q3 | $306K | Buy |
+9,044
| New | +$306K | ﹤0.01% | 1161 |
|
|
2020
Q4 | – | Sell |
-179,631
| Closed | -$3.74M | – | 2528 |
|
|
2020
Q3 | $3.74M | Buy |
179,631
+22,313
| +14% | +$465K | 0.01% | 1290 |
|
|
2020
Q2 | $3.74M | Buy |
157,318
+129,018
| +456% | +$3.06M | 0.01% | 1183 |
|
|
2020
Q1 | $509K | Sell |
28,300
-23,481
| -45% | -$422K | ﹤0.01% | 1525 |
|
|
2019
Q4 | $1.23M | Buy |
+51,781
| New | +$1.23M | ﹤0.01% | 1286 |
|
|
2019
Q2 | – | Sell |
-35,836
| Closed | -$1.26M | – | 1685 |
|
|
2019
Q1 | $1.26M | Buy |
+35,836
| New | +$1.26M | ﹤0.01% | 1258 |
|
|
2016
Q4 | – | Sell |
-9,667
| Closed | -$239K | – | 2427 |
|
|
2016
Q3 | $239K | Buy |
+9,667
| New | +$239K | ﹤0.01% | 1390 |
|
|
2016
Q1 | – | Sell |
-70,600
| Closed | -$949K | – | 1515 |
|
|
2015
Q4 | $949K | Buy |
+70,600
| New | +$949K | ﹤0.01% | 1003 |
|